Monoamine Transporter

Monoamine transporter inhibitors block reuptake of dopamine, noradrenaline and serotonin into neurons or vesicles. Plasma membrane transporters for dopamine (DAT), noradrenaline (NET) and serotonin (SERT) clear released transmitter from the synapse. Mice lacking DAT show hyperlocomotion and no response to cocaine or amphetamine, which identified this transporter as their main target. Vanoxerine 2HCl and GBR 12783 dihydrochloride are selective dopamine uptake inhibitors. Milnacipran hydrochloride inhibits both serotonin and noradrenaline reuptake at the plasma membrane. Vesicular monoamine transporters (VMAT) load monoamines into synaptic vesicles and are inhibited by reserpine. GZ-793A is a more selective inhibitor of the VMAT2 isoform.

2 Items

  • NMDAR antagonist 5
    Cat. No.
    A67402

    NMDAR antagonist 5

    NMDAR antagonist 5 (Compound A17) is a selective antagonist targeting the N-methyl-D-aspartate receptor (NMDAR) with an IC50 of 0.3 µM. This compound also inhibits monoamine transporters, including the serotonin transporter (SERT, IC50 = 1.1 µM), dopamine transporter (DAT, IC50 = 0.7 µM), and norepinephrine transporter (NET, IC50 = 2.7 µM). With a favorable safety profile and low toxicity across multiple organ systems, NMDAR antagonist 5 demonstrates potential antidepressant effects, making it a valuable tool for research into depression and related neurological disorders.

    Out of stock

    All 3 sizes
  • Brasofensine
    Cat. No.
    A79115

    Brasofensine

    Synonyms: BMS-204756

    Brasofensine is a potent oral-active dopamine transporter antagonist. Its primary mechanism involves blocking the reuptake of monoamines, which enhances dopaminergic signaling. This compound is primarily utilized in research related to Parkinson's disease, contributing to studies focused on dopaminergic dysfunction and potential therapeutic strategies.

    25 mg
    $1,530.00
    50 mg
    $1,950.00
    All 3 sizes

2 Items

Added to your cart

View Cart Checkout

    Loading...